Announcements, events, funding opportunities and more news for the Mass General Research Institute community. |
|
In this edition:
(Scroll down for more info and click on the links for additional details)
Funding Opportunities:
• Fund for Medical Discovery (FMD) Research Fellowship Awards
• NIHM Instrumentation Program
• Limited Submission Funding Opportunities
• Foundation Funding Opportunities
Announcements:
• GraphPad Prism Software: Annual License Renewal and Signup
• New Software Opportunity: ChemDraw
• Bio Render
• August ERIS Virtual Office Hours
• Translational In-Kind Program - Mass General Brigham Innovation – Boston Scientific Corp
Events:
• Fifth Annual Neuroscience Day
• Feasibility and Acceptability of a Digitally-Enabled Community Health Worker Intervention for Patients with Heart Failure: A Single Arm Pilot Study
|
|
Fund for Medical Discovery (FMD) Research Fellowship Awards
Applications are now being accepted by the Executive Committee on Research (ECOR) for the Fund for Medical Discovery (FMD) Research Fellowship Awards!
We recognize that research at MGH integrates the full translational spectrum of discovery from "bench to bedside to community and population.” To ensure that all areas of research conducted at MGH are included and eligible for FMD fellowship awards, ECOR is offering 3 types of training awards: fundamental research fellowships, clinical research fellowships, and population health care sciences fellowships. These fellowships are for MD and PhD Research Fellows and Clinical Research Fellows who are in the training phase of their research at MGH. Instructors who are within 5 years total since initiating their research fellowship training are only eligible to apply for the clinical and population health care sciences fellowships.
How much is each award?
The award will include a stipend of $54,840 plus applicable fringe benefits and 20% indirect costs.
When is the deadline?
Monday, October 3, 2022 - 5:00 PM
How do I learn more and apply?
For a guide to help make your application more competitive click here.
|
|
NIMH Instrumentation Program
The NIMH Instrumentation Program (S10) encourages applications from NIH funded investigators that conduct mental health-related research to purchase or upgrade a single commercially available instrument or a group of components to create an instrument that is not commercially available.
If you are interested in applying for this grant, please fill out this NIMH S10 application form and return it to ecor@mgh.harvard.edu by Wednesday, September 7, 2022. We encourage applicants to continue working on their NIH application while ECOR reviews your internal LOI.
The NIH deadline for applications is October 7, 2022, so we would greatly appreciate your notification of interest as soon as possible.
|
|
Limited Submission Funding Opportunities
We ask that all MGH Investigators interested in applying for any limited submission award submit a Letter of Intent (see detailed instructions below) to the MGH Executive Committee on Research (ECOR) by the deadline indicated for each award to be considered to receive an institutional nomination.
CURRENT OPPORTUNITIES:
Modern Equipment for Shared-use Biomedical Research Facilities: Advancing Research Related Operations (R24 Clinical Trials Not Allowed) -- Invites qualified academic or research institutions to apply for funding to support the purchase of advanced equipment that will enhance and modernize research operations.
NICHD Global Network for Women’s and Children’s Health Research: Research Units (UG1 Clinical Trial Optional) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions in partnership with research centers in low and middle-income countries to submit applications as Research Units (RUs) to participate in the Global Network for Women’s and Children’s Health Research.
NICHD Global Network for Women’s and Children’s Health Research: Data Coordinating Center (U24 Clinical Trial Optional) The Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) invites U.S. institutions to submit applications to participate in the Global Network for Women’s and Children’s Health Research’s Data Coordinating Center.
National Institute of Allergy and Infectious Disease (NIAID) Clinical Data and Safety Management Center (CDSMC) (U01 Clinical Trial Not Allowed) – NEW! The purpose of this Funding Opportunity Announcement (FOA) is to solicit applications for the NIAID CDSMC, which will support a broad range of critical support services
George M. O'Brien Kidney National Resource Centers (U54 -- Clinical Trial Not Allowed): Join a consortium that is leading a nation-wide effort to advance kidney research.
National Coordinating Center for the George M. O’Brien Kidney National Resource Centers (U24 – Clinical Trial Not Allowed) The National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) invites applications for the George M. O’Brien Kidney Consortium --National Resource Centers (NRCs) to lead a nation-wide effort to advance kidney research.
Coordinating Center for the NICHD Population Dynamics Centers Research Infrastructure Program FY 2023 (R24 Clinical Trial Not Allowed) The purpose of this funding announcement is to support a coordinating center for the NICHD Population Dynamics Centers Research Infrastructure Program (PDRIP).
Postbaccalaureate Research Education Program (PREP) (R25 – Independent Clinical Trial Not Allowed) The NIH Research Education Program (R25) supports research education activities in the mission areas of the NIH. The overarching goal of this R25 program is to support educational activities that encourage individuals from diverse backgrounds, including those from groups underrepresented in the biomedical and behavioral sciences, to pursue further studies or careers in research.
|
|
Foundation Funding Opportunities
Please contact Corporate & Foundation Relations in the Office of Development at devcfr@mgh.harvard.edu if you wish to submit a proposal in response to any of these opportunities. Note that proposals are still routed through the standard InfoEd/Research Management process.
CURRENT OPPORTUNITIES:
|
|
In-Cycle Grant Opportunities: Bridge Grant, Alpha-1 Foundation (A1F). $25,000. LOI Deadline: September 30
In-Cycle Grant Opportunities: Pilot and Feasibility Grant, Alpha-1 Foundation (A1F). $75,000. LOI Deadline: September 30
In-Cycle Grant Opportunities: Postdoctoral Research Fellowship Grant, Alpha-1 Foundation (A1F). $150,000. LOI Deadline: September 30
In-Cycle Grant Opportunities: Research Grant, Alpha-1 Foundation (A1F). $200,000. LOI Deadline: September 30
AACR-Novocure Career Development Award for Tumor Treating Fields Research in Ovarian Cancer, American Association for Cancer Research (AACR). $300,000. Application Deadline: September 20
AACR-Novocure Tumor Treating Fields in NSCLC Research Grant, American Association for Cancer Research (AACR). $350,000. Application Deadline: September 20
NEW! AGA-Gastric Cancer Foundation Ben Feinstein Memorial Research Scholar Award in Gastric Cancer, American Gastroenterological Association (AGA) Research Foundation. $300,000. Application Deadline: November 9
Research Scholar Award (RSA), American Gastroenterological Association (AGA) Research Foundation. $300,000. Application Deadline: November 9
Clinical Pilot and Feasibility Awards, Cystic Fibrosis Foundation (CFF)/Cystic Fibrosis Foundation Therapeutics, Inc. (CFFT). $300,000. LOI Deadline: September 16
Clinical Research Award, Cystic Fibrosis Foundation (CFF). $1.05 million. LOI Deadline: September 16
NEW! Innovation Challenge: Data-Driven Inclusion for Older People and People with Disabilities, Enhancing Learning and Research for Humanitarian Assistance (ELRHA). ≈ $211,000. EOI Deadline: September 14
Bits to Bytes, Massachusetts Life Sciences Center. $750,000. Application Deadline: November 18
Novel Therapeutics Delivery, Massachusetts Life Sciences Center. $750,000. Application Deadline: November 18
Research Infrastructure Program, Massachusetts Life Sciences Center. $5 million. Application Deadline: November 18
Oncomine Clinical Research Grant Program, Thermo Fisher Scientific. $200,000. Proposal Deadline: September 23
|
|
If you have a GraphPad Prism license through the Research Computing Core, it's time to renew. Annual licenses expire each year on August 31st, but the new license is available now! To prevent a break in service, request a software license through the ERIS Research Computing Core Service Catalog. The annual fee is $40/license. More information about Prism, and other software offerings are on the ERIS Research Computing Core site.
|
|
ChemDraw licenses are offered at a discounted rate through the ERIS Research Computing Core. ChemDraw is a powerful, yet easy-to use, tool for producing chemical and biological drawings. You can create your own drawings or use those provided in the library of available templates. This is a subscription service with an annual fee, which must be renewed each May 19th, to continue access. Once ordering you will receive an email with installation instructions (new users) or an activation code (renewals). Request through the ERIS Research Computing Core Service Catalog.
|
|
Licenses are available at a discounted rate through the Research Computing Core. BioRender is a web application that can be used to create scientific figures, diagrams, and illustrations from a scientifically accurate image library, all in a matter of minutes. Using a simple drag and drop model, BioRender will save you time, so you can focus more on the science and less on illustration. BioRender requires no installation and you may log into your account on any computer, to access the BioRender portal. For more information on BioRender, go to the Research Computing Core's software page or order now at rcservices.partners.org (MGB login required). All questions may be directed to rcc@partners.org
|
|
-
Virtual ERIS Office Hours, Subject matter experts will be online to help you navigate RISC tools and services available to support research and innovation.
- August 22, 2022 2:00 pm to 3:00 pm
|
|
Translational In-Kind Program - Mass General Brigham Innovation – Boston Scientific Corp
A partnership between Mass General Brigham and Boston Scientific Corp. (BSC) aims to give MGB investigators, including clinicians and researchers, an opportunity to receive in-kind expert industry resources for their promising early-stage idea or product. This is not a funding proposal. Of specific interest are early innovations, including devices and software at the ideation/prototyping phase.
Non-confidential proposals must be submitted by September 15, 2022
Key Dates and Information
-
Non-confidential proposals must be submitted by September 15, 2022
- Those with successful proposals will be invited to give a 20-minute confidential pitch to a panel of MGB and BSC decision-makers through December 15, 2022
- Final decisions to follow
-
12-month project periods are anticipated.
|
|
|
|
Fifth Annual Neuroscience Day: Thursday, September 15, 8:30-3:00 PM |
The theme of this years event is Gene, Cell and ASO Therapies and the keynote address (and Grand Rounds presentation) will be given by Frank Bennett, PhD, the executive vice president and chief scientific officer at Ionis Pharmaceuticals and one of the founding members of the company.
|
|
|
|
Feasibility and Acceptability of a Digitally-Enabled Community Health Worker Intervention for Patients with Heart Failure: A Single Arm Pilot Study |
Jocelyn Carter, MD, MPH
DGIM Physician-Scientist and Internal Medicine Hospitalist / Albright Medicine
Director, MGH Community CAre Transitions (C-CAT) Initiative
Director of Research Equity, Division of General Internal Medicine
Manager of Trainee Affairs, Center for Diversity and Inclusion
Elected Representative, MGH Executive Committee on Research
Department of Medicine, Massachusetts General Hospital
Assistant Professor of Medicine, Harvard Medical School
Wednesday, September 21, 2022
1:30 – 2:30p
|
|
|
|
|
|
|
